nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol valerate/Dienogest—Mood alteration NOS—Capecitabine—esophageal cancer	0.057	0.0674	CcSEcCtD
Estradiol valerate/Dienogest—Mood alteration NOS—Methotrexate—esophageal cancer	0.0424	0.0502	CcSEcCtD
Estradiol valerate/Dienogest—Ethinyl Estradiol—NR1I2—esophageal cancer	0.03	0.194	CrCbGaD
Estradiol valerate/Dienogest—Nandrolone phenpropionate—CYP19A1—esophageal cancer	0.0298	0.193	CrCbGaD
Estradiol valerate/Dienogest—Depressed mood—Capecitabine—esophageal cancer	0.0256	0.0303	CcSEcCtD
Estradiol valerate/Dienogest—Nandrolone decanoate—CYP19A1—esophageal cancer	0.0226	0.146	CrCbGaD
Estradiol valerate/Dienogest—Dementia—Methotrexate—esophageal cancer	0.0207	0.0245	CcSEcCtD
Estradiol valerate/Dienogest—Estradiol—NR1I2—esophageal cancer	0.0198	0.128	CrCbGaD
Estradiol valerate/Dienogest—Hirsutism—Capecitabine—esophageal cancer	0.0197	0.0233	CcSEcCtD
Estradiol valerate/Dienogest—Tenderness—Cisplatin—esophageal cancer	0.0178	0.021	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Carboplatin—esophageal cancer	0.0161	0.0191	CcSEcCtD
Estradiol valerate/Dienogest—Metrorrhagia—Capecitabine—esophageal cancer	0.016	0.0189	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.0154	0.0183	CcSEcCtD
Estradiol valerate/Dienogest—Estrone—CYP1B1—esophageal cancer	0.015	0.0972	CrCbGaD
Estradiol valerate/Dienogest—Vaginal discharge—Methotrexate—esophageal cancer	0.014	0.0166	CcSEcCtD
Estradiol valerate/Dienogest—Ethinyl Estradiol—ABCC2—esophageal cancer	0.0135	0.087	CrCbGaD
Estradiol valerate/Dienogest—Hypocalcaemia—Capecitabine—esophageal cancer	0.0125	0.0148	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Cisplatin—esophageal cancer	0.0115	0.0136	CcSEcCtD
Estradiol valerate/Dienogest—Blood pressure increased—Capecitabine—esophageal cancer	0.0114	0.0135	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Capecitabine—esophageal cancer	0.0114	0.0135	CcSEcCtD
Estradiol valerate/Dienogest—Estradiol—CYP1B1—esophageal cancer	0.0114	0.0736	CrCbGaD
Estradiol valerate/Dienogest—Irritability—Cisplatin—esophageal cancer	0.0107	0.0127	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Cisplatin—esophageal cancer	0.0102	0.012	CcSEcCtD
Estradiol valerate/Dienogest—Cramp muscle—Cisplatin—esophageal cancer	0.0101	0.012	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Capecitabine—esophageal cancer	0.00959	0.0113	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Cisplatin—esophageal cancer	0.00954	0.0113	CcSEcCtD
Estradiol valerate/Dienogest—Libido decreased—Capecitabine—esophageal cancer	0.00895	0.0106	CcSEcCtD
Estradiol valerate/Dienogest—Purpura—Capecitabine—esophageal cancer	0.00861	0.0102	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00855	0.0101	CcSEcCtD
Estradiol valerate/Dienogest—Pulmonary embolism—Methotrexate—esophageal cancer	0.00851	0.0101	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal inflammation—Methotrexate—esophageal cancer	0.00851	0.0101	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Cisplatin—esophageal cancer	0.00851	0.0101	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00847	0.01	CcSEcCtD
Estradiol valerate/Dienogest—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00823	0.00974	CcSEcCtD
Estradiol valerate/Dienogest—Migraine—Capecitabine—esophageal cancer	0.00817	0.00966	CcSEcCtD
Estradiol valerate/Dienogest—Vaginal infection—Methotrexate—esophageal cancer	0.00804	0.00951	CcSEcCtD
Estradiol valerate/Dienogest—Irritability—Capecitabine—esophageal cancer	0.00792	0.00937	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Capecitabine—esophageal cancer	0.00786	0.0093	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Cisplatin—esophageal cancer	0.00765	0.00906	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Cisplatin—esophageal cancer	0.00751	0.00888	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Capecitabine—esophageal cancer	0.0075	0.00887	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Cisplatin—esophageal cancer	0.00728	0.00861	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Cisplatin—esophageal cancer	0.00723	0.00855	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal distension—Capecitabine—esophageal cancer	0.00722	0.00854	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Capecitabine—esophageal cancer	0.00717	0.00849	CcSEcCtD
Estradiol valerate/Dienogest—Thrombophlebitis—Methotrexate—esophageal cancer	0.00714	0.00844	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Cisplatin—esophageal cancer	0.00704	0.00832	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Cisplatin—esophageal cancer	0.00678	0.00802	CcSEcCtD
Estradiol valerate/Dienogest—Flatulence—Cisplatin—esophageal cancer	0.00668	0.0079	CcSEcCtD
Estradiol valerate/Dienogest—Weight increased—Capecitabine—esophageal cancer	0.00653	0.00772	CcSEcCtD
Estradiol valerate/Dienogest—Visual disturbance—Methotrexate—esophageal cancer	0.00652	0.00771	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Cisplatin—esophageal cancer	0.00652	0.00771	CcSEcCtD
Estradiol valerate/Dienogest—Weight decreased—Capecitabine—esophageal cancer	0.00649	0.00768	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Capecitabine—esophageal cancer	0.00638	0.00754	CcSEcCtD
Estradiol valerate/Dienogest—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00631	0.00746	CcSEcCtD
Estradiol valerate/Dienogest—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00631	0.00746	CcSEcCtD
Estradiol valerate/Dienogest—Myocardial infarction—Capecitabine—esophageal cancer	0.00627	0.00742	CcSEcCtD
Estradiol valerate/Dienogest—Irritability—Methotrexate—esophageal cancer	0.0059	0.00698	CcSEcCtD
Estradiol valerate/Dienogest—Mood swings—Methotrexate—esophageal cancer	0.00585	0.00692	CcSEcCtD
Estradiol valerate/Dienogest—Anxiety—Cisplatin—esophageal cancer	0.00575	0.00681	CcSEcCtD
Estradiol valerate/Dienogest—Connective tissue disorder—Capecitabine—esophageal cancer	0.00564	0.00667	CcSEcCtD
Estradiol valerate/Dienogest—Breast disorder—Methotrexate—esophageal cancer	0.00558	0.00661	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Cisplatin—esophageal cancer	0.00553	0.00655	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Cisplatin—esophageal cancer	0.00553	0.00655	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Capecitabine—esophageal cancer	0.00553	0.00655	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Capecitabine—esophageal cancer	0.00543	0.00642	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Cisplatin—esophageal cancer	0.00543	0.00642	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Capecitabine—esophageal cancer	0.00537	0.00635	CcSEcCtD
Estradiol valerate/Dienogest—Asthma—Methotrexate—esophageal cancer	0.00534	0.00632	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Capecitabine—esophageal cancer	0.00533	0.0063	CcSEcCtD
Estradiol valerate/Dienogest—Pancreatitis—Methotrexate—esophageal cancer	0.00524	0.00619	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Capecitabine—esophageal cancer	0.00519	0.00614	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Capecitabine—esophageal cancer	0.00503	0.00595	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Capecitabine—esophageal cancer	0.005	0.00591	CcSEcCtD
Estradiol valerate/Dienogest—Ethinyl Estradiol—ABCB1—esophageal cancer	0.00495	0.032	CrCbGaD
Estradiol valerate/Dienogest—Flatulence—Capecitabine—esophageal cancer	0.00493	0.00583	CcSEcCtD
Estradiol valerate/Dienogest—Muscle spasms—Capecitabine—esophageal cancer	0.00481	0.00568	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00478	0.00565	CcSEcCtD
Estradiol valerate/Dienogest—Depression—Methotrexate—esophageal cancer	0.00475	0.00562	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Cisplatin—esophageal cancer	0.00473	0.0056	CcSEcCtD
Estradiol valerate/Dienogest—Palpitations—Capecitabine—esophageal cancer	0.00442	0.00523	CcSEcCtD
Estradiol valerate/Dienogest—Estrone—ABCB1—esophageal cancer	0.00431	0.0279	CrCbGaD
Estradiol valerate/Dienogest—Anxiety—Capecitabine—esophageal cancer	0.00424	0.00502	CcSEcCtD
Estradiol valerate/Dienogest—Visual impairment—Methotrexate—esophageal cancer	0.00412	0.00487	CcSEcCtD
Estradiol valerate/Dienogest—Oedema—Capecitabine—esophageal cancer	0.00408	0.00483	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Cisplatin—esophageal cancer	0.00408	0.00482	CcSEcCtD
Estradiol valerate/Dienogest—Erythema multiforme—Methotrexate—esophageal cancer	0.00404	0.00478	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Capecitabine—esophageal cancer	0.004	0.00473	CcSEcCtD
Estradiol valerate/Dienogest—Eye disorder—Methotrexate—esophageal cancer	0.00399	0.00473	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Cisplatin—esophageal cancer	0.00397	0.0047	CcSEcCtD
Estradiol valerate/Dienogest—Cardiac disorder—Methotrexate—esophageal cancer	0.00397	0.00469	CcSEcCtD
Estradiol valerate/Dienogest—Immune system disorder—Methotrexate—esophageal cancer	0.00386	0.00457	CcSEcCtD
Estradiol valerate/Dienogest—Mental disorder—Methotrexate—esophageal cancer	0.00374	0.00443	CcSEcCtD
Estradiol valerate/Dienogest—Malnutrition—Methotrexate—esophageal cancer	0.00372	0.0044	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Capecitabine—esophageal cancer	0.00359	0.00425	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00352	0.00417	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Cisplatin—esophageal cancer	0.00352	0.00416	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Capecitabine—esophageal cancer	0.00352	0.00416	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Cisplatin—esophageal cancer	0.00349	0.00413	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Capecitabine—esophageal cancer	0.00349	0.00413	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Cisplatin—esophageal cancer	0.00349	0.00412	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00334	0.00395	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Cisplatin—esophageal cancer	0.00329	0.00389	CcSEcCtD
Estradiol valerate/Dienogest—Estradiol—ABCB1—esophageal cancer	0.00327	0.0211	CrCbGaD
Estradiol valerate/Dienogest—Urticaria—Capecitabine—esophageal cancer	0.00324	0.00383	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Capecitabine—esophageal cancer	0.00322	0.00381	CcSEcCtD
Estradiol valerate/Dienogest—Anaphylactic shock—Methotrexate—esophageal cancer	0.00304	0.00359	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Capecitabine—esophageal cancer	0.00301	0.00356	CcSEcCtD
Estradiol valerate/Dienogest—Nervous system disorder—Methotrexate—esophageal cancer	0.00298	0.00352	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Capecitabine—esophageal cancer	0.00293	0.00346	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Capecitabine—esophageal cancer	0.00289	0.00341	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Capecitabine—esophageal cancer	0.0027	0.00319	CcSEcCtD
Estradiol valerate/Dienogest—Dyspepsia—Methotrexate—esophageal cancer	0.00267	0.00316	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00262	0.0031	CcSEcCtD
Estradiol valerate/Dienogest—Fatigue—Methotrexate—esophageal cancer	0.00262	0.0031	CcSEcCtD
Estradiol valerate/Dienogest—Pain—Methotrexate—esophageal cancer	0.0026	0.00307	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Capecitabine—esophageal cancer	0.00259	0.00307	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Capecitabine—esophageal cancer	0.00257	0.00304	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Capecitabine—esophageal cancer	0.00257	0.00304	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Capecitabine—esophageal cancer	0.00256	0.00302	CcSEcCtD
Estradiol valerate/Dienogest—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00248	0.00294	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Capecitabine—esophageal cancer	0.00242	0.00287	CcSEcCtD
Estradiol valerate/Dienogest—Urticaria—Methotrexate—esophageal cancer	0.00241	0.00285	CcSEcCtD
Estradiol valerate/Dienogest—Abdominal pain—Methotrexate—esophageal cancer	0.0024	0.00284	CcSEcCtD
Estradiol valerate/Dienogest—Hypersensitivity—Methotrexate—esophageal cancer	0.00224	0.00265	CcSEcCtD
Estradiol valerate/Dienogest—Asthenia—Methotrexate—esophageal cancer	0.00218	0.00258	CcSEcCtD
Estradiol valerate/Dienogest—Pruritus—Methotrexate—esophageal cancer	0.00215	0.00254	CcSEcCtD
Estradiol valerate/Dienogest—Dizziness—Methotrexate—esophageal cancer	0.00201	0.00238	CcSEcCtD
Estradiol valerate/Dienogest—Vomiting—Methotrexate—esophageal cancer	0.00193	0.00228	CcSEcCtD
Estradiol valerate/Dienogest—Rash—Methotrexate—esophageal cancer	0.00191	0.00227	CcSEcCtD
Estradiol valerate/Dienogest—Dermatitis—Methotrexate—esophageal cancer	0.00191	0.00226	CcSEcCtD
Estradiol valerate/Dienogest—Headache—Methotrexate—esophageal cancer	0.0019	0.00225	CcSEcCtD
Estradiol valerate/Dienogest—Nausea—Methotrexate—esophageal cancer	0.0018	0.00213	CcSEcCtD
